Search Results for 'covid-19'
-
Biologics, Proteins, Vaccines | Breaking News
FDA Issues Guidance on EUA for COVID-19 Vaccines
Provides further information on the EUA process for investigational vaccines.Contract Pharma Staff 10.07.20
-
Parenterals
Primary Packaging Considerations Amid COVID-19 Vax Urgency
Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.Online Exclusives Kristin Brooks, Contract Pharma 10.05.20
-
Cold Chain Management | Logistics | Supply Chain
Pharma Supply Chain Logistics & Potential COVID-19 Vaccines
Wes Wheeler of UPS Healthcare explores various complexities, how to minimize supply chain gaps and challenges across the nation and globally.Online Exclusives Kristin Brooks, Contract Pharma 09.17.20
-
Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
Expediting a COVID-19 Vaccine: FDA Approval Process
The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.Kristin Brooks, Managing Editor 09.09.20
-
Logistics | Supply Chain
Is Blockchain Key to COVID-19 Vaccine Distribution?
The global supply chain has taken a huge hit over the last several months, what role might blockchain play when it comes to vaccine distribution.Online Exclusives Kristin Brooks, Contract Pharma 08.05.20
-
FDA COVID-19 Update
FDA has authorized 141 tests under EUAs; these include 120 molecular tests, 20 antibody tests, and 1 antigen test.Contract Pharma Staff 06.19.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationOnline Exclusives Kristin Brooks, Contract Pharma 05.18.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Biologics, Proteins, Vaccines
Covid 19: Impact on Bioprocessing and Outsourcing
Outsourcing of biologics is increasing due to Covid-19, but what will change in the long-run?Ronald A. Rader & Eric S. Langer, BioPlan Associates 05.05.20
-
Breaking News | Industry News
Eagle Pharma’s Drug Shows Antiviral Activity Against COVID-19
IND submitted to FDA for clinical study at Hackensack University Medical Center to evaluate Ryanodex for treatment of COVID-19 patientsContract Pharma Staff 04.17.20
